Phase 3 study demonstrated that efanesoctocog alfa met both primary and secondary endpoints

Research concerns ACD440 – a non-opioid drug which treats peripheral neuropathic pain

A research team has developed a novel chemical tool to reveal how bacteria adapt to the host environment […]

Lithuanian researcher from Kaunas University of Technology (KTU), Rytis Maskeliūnas, together with colleagues from the Lithuanian University of […]

Lilly is calling for Government to freeze the statutory scheme repayment rate for 2023

Acepiro tablets for respiratory diseases will be available across the UK prescription market

A multi-disciplinary team of researchers has developed a way to monitor the progression of movement disorders using motion […]

It has been shown that the percentage of ankle fractures that undergo surgery could be substantially reduced, from […]

Findings in animal models show that a U.S. Food and Drug Administration (FDA)-approved antibiotic regimen for multidrug-resistant (MDR) […]

Chemists designed a bottlebrush-shaped nanoparticle that can be loaded with multiple drugs, in ratios that can be easily […]